VIA EDGAR
October 16, 2019
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, NE
Washington, D.C. 20549
Attn: Sonia Bednarowski
|
Re: |
Odonate Therapeutics, Inc. |
Registration Statement on Form S-3
Filed September 27, 2019
File No. 333-233990
Dear Ms. Bednarowski:
Odonate Therapeutics, Inc., a Delaware corporation (the “Company”), respectfully requests pursuant to Rule 461 under the Securities Act of 1933, as amended, that the effective date of the Company’s Registration Statement on Form S-3 (File No. 333-233990) be accelerated and that it be declared effective on October 18, 2019 at 4:00 p.m. Eastern Time, or as soon as practicable thereafter.
|
|
|
|
Sincerely,
|
|
|
|
|
|
/s/ John Lemkey |
|
|
|
|
|
John Lemkey |
|
|
|
|
|
Chief Operating Officer |
|
|
cc: |
Ryan Murr, Gibson, Dunn & Crutcher LLP |
